Start date: 03.06.2020
Sara completed her Master’s in Industrial Biotechnology at University of Tehran, Iran in 2019. During her studies she worked on modification of electrodes with reduced graphene oxide, gold nanoparticles and aptamers for applying them in an electrochemical system in order to detect trace amounts of LPS, as a microbial toxin. During this time she developed a strong interest in integrating science with technology specially for healthcare purposes.
In December 2019, she joined the Department of Biomedical and Clinical Sciences at Linköping University, where she would carry out her PhD studies with a focus on using organic electrochemical transistors (OECTs) for detecting biomarkers involved in diagnosis and prognosis of multiple sclerosis (MS) as part of the BORGES project. Her research will also involve discovering of novel biomarkers, in body fluids such as CSF and plasma, that show correlations with stage of the disease or efficacy of a certain treatment.